Jun 28, 2021

This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.

Jun 24, 2021

Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.

Jun 21, 2021

This first installment of a 2-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology. 

Jun 19, 2021

Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.

Jun 17, 2021

Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.